{
  "meta": {
    "title": "11_Depressive_Disorders",
    "url": "https://brainandscalpel.vercel.app/11-depressive-disorders-6850a421.html",
    "scrapedAt": "2025-11-30T12:35:15.527Z"
  },
  "questions": [
    {
      "text": "According to the latest  WHO statistics, what is the most common psychiatric disorder in the world?",
      "choices": [
        {
          "id": 1,
          "text": "Eating disorder"
        },
        {
          "id": 2,
          "text": "Depression"
        },
        {
          "id": 3,
          "text": "Bipolar disorder"
        },
        {
          "id": 4,
          "text": "Anxiety disorder"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>According to the WHO global health statistics 2020, <strong>anxiety disorder</strong> is the <strong>most common</strong>&nbsp;psychiatric illness in the world.</p><p>Mental health day theme for 2022 is&nbsp;<strong>Making Mental Health &amp; Well-Being for All a Global Priority.&nbsp;</strong></p>\n<p>World mental health day is observed<strong> on 10<sup>th</sup>&nbsp;October.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6669",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is a  component of  Beck's triad of depression ?",
      "choices": [
        {
          "id": 1,
          "text": "Worthlessness"
        },
        {
          "id": 2,
          "text": "Anhedonia"
        },
        {
          "id": 3,
          "text": "Low mood"
        },
        {
          "id": 4,
          "text": "Fatigability"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Worthlessness</strong> is a component of&nbsp;Beck's cognitive <strong>triad of depression</strong>.&nbsp;It is also known as the negative triad.&nbsp;</p>\n<p><strong>Aaron Beck's cognitive triad</strong> consists of:</p>\n<ol>\n<li>Negative views about one's self - A tendency to devalue to feel personally inadequate (<strong>Worthlessness</strong>)</li>\n<li>Negative views about the world - A tendency to feel that there is no help available (<strong>Helplessness</strong>)</li>\n<li>Negative views about the future - The expectation of suffering and failure (<strong>Hopelessness</strong>)</li>\n</ol>\n<p><strong>Anhedonia</strong> - Decreased ability to experience pleasure.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6671",
      "difficulty": "easy"
    },
    {
      "text": "A 45-year-old man continues to smoke despite several attempts at quitting because he believes that he will always be a smoker. Which of the following theories best describes this behavior?",
      "choices": [
        {
          "id": 1,
          "text": "Learned helplessness theory"
        },
        {
          "id": 2,
          "text": "Theory of psychosocial development"
        },
        {
          "id": 3,
          "text": "Psychodynamic theory"
        },
        {
          "id": 4,
          "text": "Social learning theory"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario is suggestive of the&nbsp;<strong>learned helplessness theory </strong>of depression.&nbsp;The theory connects depressive phenomena to the experience of uncontrollable events. It was proposed by Martin Seligman.&nbsp;</p>\n<p>Another good example of this can be a situation of domestic abuse where women tend to leave several times before doing so for good. A person may believe that they can never escape the abuser, even when help and support are available.</p>\n<p>Option B: The<strong> theory of</strong> <strong>psychosocial development</strong> was proposed by Erik Erikson. There are&nbsp;<strong>8 stages</strong> of psychosocial <strong>development.</strong> He states that&nbsp;there are critical time periods, each of which poses a particular <strong>psychosocial conflict</strong> to the individual. The resolution of this conflict results in either psychosocial growth or regression.</p>\n<p>Option C: <strong>Psychodynamic theory of development </strong>explains personality in terms of the interaction between the conscious and unconscious forces of <strong>Id, ego, and super-ego.</strong></p>\n<p>Option D: <strong>Social learning theory</strong> is a theory of learning process and social behavior which proposes that new behaviors can be acquired by observing and imitating others.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0997",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year-old woman is brought to the psychiatry OPD with low mood for the past 2 weeks, reduced socialization, decreased appetite and inability to sleep for the past 3 months. She complains of frequent backache and headache, with early morning awakening. Which of the following is increased in this disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Cortisol"
        },
        {
          "id": 2,
          "text": "Dopamine"
        },
        {
          "id": 3,
          "text": "Norepinephrine"
        },
        {
          "id": 4,
          "text": "Serotonin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of low mood along with reduced appetite, reduced interest in socialization, somatic symptoms, and disturbed sleep, points towards a diagnosis of <strong>depression (major depressive disorder).&nbsp;Cortisol</strong>&nbsp;levels are <strong>increased</strong> in depression.&nbsp;&nbsp;</p>\n<p>The diagnostic criteria for major depressive disorder are as follows:</p>\n<p>A. <strong>Five or more</strong> of the following symptoms have been present during the <strong>same 2 week period.&nbsp;</strong>At least<strong> one of the symptoms</strong> is either <strong>depressed mood</strong> or <strong>loss of interest</strong> or pleasure.</p>\n<ol>\n<li>Depressed mood most of the day</li>\n<li>Markedly diminished interest or pleasure in activities (anhedonia)</li>\n<li>Significant weight loss (loss of more than 5% of body weight in a month) when not dieting or weight gain, decrease or increase in appetite&nbsp;</li>\n<li>Insomnia or hypersomnia</li>\n<li>Psychomotor agitation or retardation</li>\n<li>Fatigue or loss of energy</li>\n<li>Feelings of worthlessness or excessive or inappropriate guilt</li>\n<li>Diminished ability to think or concentrate, or indecisiveness</li>\n<li>Recurrent thoughts of death, recurrent suicidal ideation</li>\n</ol>\n<p>B. The symptoms cause clinically significant <strong>distress or impairment</strong> in social, occupa&shy;tional, or other important areas of functioning.</p>\n<p>C. The episode is <strong>not attributable </strong>to the physiological effects of a<strong> substance</strong> or to another <strong>medical condition</strong>.</p>\n<p>D. The occurrence of the major depressive episode is not better explained by:</p>\n<ul>\n<li>Schizoaf&shy;fective disorder</li>\n<li>Schizophrenia</li>\n<li>Schizophreniform disorder</li>\n<li>Delusional disorder</li>\n<li>Another specified or unspecified schizophrenia spectrum, or other psychotic disorders.</li>\n</ul>\n<p>E. There has <strong>never </strong>been a <strong>manic</strong> episode or a <strong>hypomanic episode</strong>.</p>\n<p>Note<strong>: </strong>The levels of norepinephrine, serotonin, and dopamine are decreased in depression</p><hr><h3>Related Pearl: Neurotransmitters</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Neuro-transmitters</strong></td>\n<td><strong>&nbsp;Major source</strong></td>\n<td><strong>&nbsp;Function</strong></td>\n<td><strong>&nbsp;Increased in</strong></td>\n<td><strong>&nbsp;Decreased in</strong></td>\n</tr>\n<tr>\n<td><strong>Serotonin</strong></td>\n<td><span>Midline Raphe Nucleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Regulation of mood, sleep, appetite, sexual behavior, decreases anxiety</span></p>\n<p><span>Inhibits the dopaminergic function</span></p>\n</td>\n<td><span>Serotonin syndrome</span></td>\n<td>\n<p><span>Depression</span></p>\n<p><span>OCD</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Dopamine</strong></td>\n<td>&nbsp;<span>Substantia Nigra</span></td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Motor movement and alertness</span></p>\n<p><span>Reward seeking, pleasure, motivation</span></p>\n<p><span>Major neurotransmitter in the basal ganglia</span></p>\n</td>\n<td>\n<p><span>Schizophrenia</span></p>\n<p><span>OCD</span></p>\n<p><span>Mania</span></p>\n<p><span>Delirium</span></p>\n</td>\n<td>\n<p><span>Parkinson's disease</span></p>\n<p><span>Depression</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Endorphins</strong></td>\n<td>&nbsp;<span>Pituitary gland</span></td>\n<td><span>Pain control, feelings of pleasure, stress reduction, \"natural opium\"</span></td>\n<td><span>Addiction</span></td>\n<td><span>Inability to combat pain</span></td>\n</tr>\n<tr>\n<td><strong>Acetylcholine</strong></td>\n<td>&nbsp;<span>Nucleus Basalis (of Meynert)</span></td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Motor movement, learning and memory</span></p>\n</td>\n<td><span>Parkinson's disease</span></td>\n<td>\n<p><span>Alzheimer's disease</span></p>\n<p><span>Delirium</span></p>\n<p><span>Dementia</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>GABA</strong></td>\n<td>&nbsp;\n<p>&nbsp;</p>\n</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Decreases anxiety and reduces insomnia</span></p>\n<p><span>Interacts with dopamine, inhibits dopaminergic neurons</span></p>\n</td>\n<td>&nbsp;</td>\n<td>\n<p><span>Anxiety</span></p>\n<p><span>Seizure disorder</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Norepinephrine</strong></td>\n<td><span>Locus ceruleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory:</strong></span></p>\n<p><span>\"Fight or flight\"</span></p>\n</td>\n<td><span>Mania</span></td>\n<td><span>Lack of energy, anhedonia in Schizophrenia,&nbsp;</span><span>Depression</span></td>\n</tr>\n<tr>\n<td><strong>Glutamate</strong></td>\n<td>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Links between neurons for learning and long term memory</span></p>\n</td>\n<td><span>Seizures</span></td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6670",
      "difficulty": "medium"
    },
    {
      "text": "A 65-year-old retired officer has been confined to his house since the COVID-19 pandemic started in March 2020. He does not have any visitors and has lost touch with his family as well. He has been having persistent feelings of low mood and sees no purpose in his life. He sometimes has thoughts about killing himself. Which of the following sleep changes occur in this disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Increased REM latency"
        },
        {
          "id": 2,
          "text": "An increase in total sleep time"
        },
        {
          "id": 3,
          "text": "Deficits of slow-wave sleep"
        },
        {
          "id": 4,
          "text": "Decreased rapid eye movement (REM) sleep"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>depression (major depressive disorder).&nbsp;</strong>It is associated with a&nbsp;<strong>premature loss of deep (slow-wave) sleep</strong>.</p>\n<p>Sleep changes in depression:</p>\n<ul>\n<li>A premature loss of deep (slow-wave) sleep</li>\n<li>An increase in nocturnal arousal manifested as:\n<ul>\n<li>An increase in nocturnal awakenings</li>\n<li>A <strong>reduction </strong>in<strong> total sleep</strong> time</li>\n<li><strong>Increased</strong> phasic rapid eye movement (<strong>REM</strong>) sleep</li>\n<li>Increased core body temperature</li>\n</ul>\n</li>\n</ul>\n<p>The combination of <strong>increased REM drive</strong> and <strong>decreased slow-wave sleep</strong> results in a significant reduction in the first period of non-REM (NREM) sleep, a phenomenon referred to as<strong> reduced REM latency</strong>.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0960",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following statement is false regarding the MRI changes seen in depression?",
      "choices": [
        {
          "id": 1,
          "text": "Reduction in volume of cingulate cortex"
        },
        {
          "id": 2,
          "text": "Compromised function in the prefrontal area during a cognitive task"
        },
        {
          "id": 3,
          "text": "Hyperactivity of the amygdala during an emotional task"
        },
        {
          "id": 4,
          "text": "Atrophy of the mesial temporal lobe"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Atrophy</strong> of the <strong>mesial temporal lobe</strong> particularly the hippocampus, entorhinal cortex and perirhinal cortex is an MRI change seen in <strong>Alzheimer's disease </strong>(and not depression).</p>\n<p>The MRI changes seen in depression are:</p>\n<ul>\n<li>Reduction in volume of cingulate cortex, prefrontal cortex, amygdala and hippocampus</li>\n<li>Compromised function in the prefrontal area during the implementation of a cognitive task</li>\n<li>Hyperactivity of the limbic system (including the amygdala) during an emotional task</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3559",
      "difficulty": "medium"
    },
    {
      "text": "You receive a referral for a patient who reports a feeling of extreme heaviness in the arms or legs. As a result, he has been finding it difficult to move his limbs. In which of the following conditions is this type of paralysis seen?",
      "choices": [
        {
          "id": 1,
          "text": "Involutional melancholia"
        },
        {
          "id": 2,
          "text": "Atypical depression"
        },
        {
          "id": 3,
          "text": "Psychotic depression"
        },
        {
          "id": 4,
          "text": "Major depression"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>leaden paralysis&nbsp;</strong>and it refers to a feeling of extreme heaviness, usually in the arms or legs resulting in the difficulty of moving the limbs. It is seen in <strong>atypical depression</strong>.</p>\n<p class=\"p1\"><span class=\"s1\">Atypical depression</span><strong>&nbsp;</strong>is characterized by:</p>\n<ol>\n<li class=\"p1\">Low mood</li>\n<li>Increased sleep</li>\n<li>Increased appetite</li>\n<li>Weight gain</li>\n<li>Becomes sensitive to any comments</li>\n<li>Leaden paralysis</li>\n</ol>\n<p>Note:&nbsp;<strong>Involutional melancholia</strong>&nbsp;is a severe depressive state seen exclusively in people between <strong>40-65 years</strong>. It is usually associated with the delusions of persecution and nihilism.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6680",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old male who lost his wife 3 months back complains that his intestines have become rotten. He feels that he is responsible for his wife's death and should be sent to prison. He complains of feeling low all the time and has lost interest in daily activities since his wife's death. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Normal grief reaction"
        },
        {
          "id": 2,
          "text": "Psychotic depression"
        },
        {
          "id": 3,
          "text": "Delusional disorder"
        },
        {
          "id": 4,
          "text": "Schizophrenia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of persistent low mood, anhedonia, guilt, and self-critical thought content along with <strong>nihilistic delusion</strong> (rotten intestine), points towards a diagnosis of <strong>major depression with psychotic features</strong>.</p>\n<p>Differentiating features of grief and depression have been enlisted in the following table:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Grief</strong></td>\n<td><strong>Depression</strong></td>\n</tr>\n<tr>\n<td>Feelings of emptyness and loss</td>\n<td>Persistent low mood and inability to anticipate pleasure</td>\n</tr>\n<tr>\n<td>Dysphoria comes in waves and tends to decrease in intentsity over time</td>\n<td>Low mood tends to be persistent and consistent</td>\n</tr>\n<tr>\n<td>Associated with thoughts and reminders of deceased/loss</td>\n<td>Not tied to specific thoughts and pre-occupations</td>\n</tr>\n<tr>\n<td>May be present along with positive emotions and humor</td>\n<td>Pervassive unhappiness and misery</td>\n</tr>\n<tr>\n<td>Thought content associated with thoughts and memories of deceased/loss</td>\n<td>Thought content associated with self-critical and pessimistic ruminations</td>\n</tr>\n<tr>\n<td>Self-esteem is generally preserved</td>\n<td>Worthlessness and self-loathing is common</td>\n</tr>\n<tr>\n<td>Ideas of death focused on joining the deceased</td>\n<td>Ideas of death focused on ending life due to hopelessness</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Tricyclic antidepressants are considered to be the first-line drugs for psychotic depression.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6682",
      "difficulty": "medium"
    },
    {
      "text": "An IT employee is feeling guilty, hopeless, and not able to concentrate on work. His symptoms started 3 years back when he entered college. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Depressive disorder"
        },
        {
          "id": 2,
          "text": "Dysthymia"
        },
        {
          "id": 3,
          "text": "Adjustment disorder"
        },
        {
          "id": 4,
          "text": "Cyclothymic disorder"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">The given clinical scenario of guilt, hopelessness, and difficulty in concentrating over a period of <strong>more than 2 years</strong>, is suggestive of <strong>dysthymia (persistent depressive disorder)</strong>.</p>\n<p>The DSM 5 and ICD-11 criteria for diagnosis of dysthymia:&nbsp;</p>\n<p>A. Depressed mood for most of the day as indicated by either subjective account or observation by others, for at&nbsp;<strong>least 2 years</strong>. In children and adolescents at&nbsp;least 1 year.</p>\n<p>B. Presence&nbsp;of<strong>&nbsp;two (or more)</strong>&nbsp;of the following while being depressed.</p>\n<ol>\n<li>Poor appetite or overeating</li>\n<li>Insomnia or hypersomnia</li>\n<li>Low energy or fatigue</li>\n<li>Low self-esteem</li>\n<li>Poor concentration and/or difficulty making decisions</li>\n<li>Feelings of hopelessness</li>\n</ol>\n<div class=\"page\" title=\"Page 212\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>C. During the 2-year period (1 year for children or adolescents) of the disturbance, the individ&shy;ual has never been without the symptoms in criteria A and B for more than 2 months at a time.</p>\n<p>D. Criteria for a major depressive disorder may be continuously present for 2 years.</p>\n<p>E. There has never been a manic episode or a hypomanic episode, and criteria have never been met for cyclothymic disorder.</p>\n<p>F. The disturbance is not better explained by a persistent schizoaffective disorder, schizophrenia, delusional disorder, or other specified or unspecified schizophrenia spectrum and other psychotic disorders.</p>\n<p>G. The symptoms are not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication) or another medical condition (e.g. hypothyroidism).</p>\n<p>H. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.</p>\n</div>\n</div>\n</div>\n<p>Option C:&nbsp;<strong>Adjustment disorder </strong>is characterized by emotional or behavioral symptoms that develop&nbsp;<strong>within 3 months of exposure</strong>&nbsp;to an identifiable stressor and usually&nbsp;<strong>do not last more than 6 months</strong>&nbsp;after the stressor ends.</p>\n<p>Option D: <strong>Cyclothymic disorder&nbsp;</strong>is symptomatically a mild form of bipolar II disorder, characterized by episodes of <strong>hypomania</strong> and <strong>mild depression</strong>.</p><hr><h3>Related Pearl: Timeline in psychiatry</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Duration</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Manic episode</strong></span></td>\n<td><span>At least 1 week</span></td>\n</tr>\n<tr>\n<td><span><strong>Hypomania</strong></span></td>\n<td><span>At least 4 consecutive days</span></td>\n</tr>\n<tr>\n<td><span><strong>Major depressive disorder</strong></span></td>\n<td>\n<p><span>Lasts 6 to12 months with episodes for 2 or more weeks</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Cyclothymia</strong></span></td>\n<td><span>At least 2 years</span></td>\n</tr>\n<tr>\n<td><span><strong>Dysthymia</strong></span></td>\n<td><span>At least 2 years</span></td>\n</tr>\n<tr>\n<td><span><strong>Maternal blues</strong></span></td>\n<td><span>Starts 2&ndash;3 days after delivery and usually resolves within 10 days</span></td>\n</tr>\n<tr>\n<td><span><strong>Postpartum mood disturbances</strong></span></td>\n<td><span>Onset within 4 weeks of delivery</span></td>\n</tr>\n<tr>\n<td><span><strong>Brief psychotic disorder</strong></span></td>\n<td><span>Lasts &lt; 1 month, usually stress-related</span></td>\n</tr>\n<tr>\n<td><span><strong>Schizophreniform disorder</strong></span></td>\n<td><span>Lasts 1-6 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Schizophrenia</strong></span></td>\n<td><span>Lasts &gt; 6 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Schizoaffective disorder</strong></span></td>\n<td><span>Lasts &gt; 2 weeks</span></td>\n</tr>\n<tr>\n<td><span><strong>Delusional disorder</strong></span></td>\n<td><span>Lasts &gt; 1 month</span></td>\n</tr>\n<tr>\n<td><span><strong>Panic disorder</strong></span></td>\n<td><span>An episode followed by 1 month of concern of additional attacks&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Specific phobia</strong></span></td>\n<td><span>Lasts &gt; 6 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Generalized anxiety disorder</strong></span></td>\n<td><span>Lasts &gt; 6 months&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Acute stress disorder</strong></span></td>\n<td><span>Lasts between 3 days and 1 month&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>PTSD</strong></span></td>\n<td><span>Lasts &gt; 1 month&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Adjustment disorder</strong></span></td>\n<td>\n<p><span>Symptoms occur within 3 months of the stressor and last &lt; 6 months</span></p>\n<p><span>May last &gt; 6 months in presence of chronic stressor</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Bulimia nervosa</strong></span></td>\n<td><span>At least 3 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Somatic symptom disorder</strong></span></td>\n<td><span>Lasts &gt; 6 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Separation anxiety disorder</strong></span></td>\n<td><span>Common onset at 7&ndash;9 years&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Tourette syndrome</strong></span></td>\n<td>\n<p><span>Onset &lt; age 18 years</span></p>\n<p><span>Tics that persist for &gt; 1 year&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>ADHD</strong></span></td>\n<td><span>Symptoms for &gt; 6 months&nbsp;</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5044",
      "difficulty": "medium"
    },
    {
      "text": "A patient comes to you with a history of persistent low mood for the past 3 years. He also complains of fatigue and insomnia during this period. He gives a history of worsening low mood over the past 3 weeks, along with suicidal thoughts and a loss of interest in all activities.  What is the probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Major depressive disorder"
        },
        {
          "id": 2,
          "text": "Dysthymia"
        },
        {
          "id": 3,
          "text": "Cyclothymia"
        },
        {
          "id": 4,
          "text": "Double depression"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Double depression</strong> is the most probable diagnosis in this scenario.&nbsp;<strong>Dysthymia</strong> and <strong>major depressive disorder</strong>&nbsp;in the <strong>same period&nbsp;</strong>constitute&nbsp;double depression.&nbsp;</p>\n<p>From the given history:</p>\n<ul>\n<li>Features of low mood, fatigue, and insomnia for more than 2 years point towards dysthymia.</li>\n<li>Features of low mood, fatigue, insomnia, anhedonia, and suicidal thoughts for more than 2 weeks point towards major depressive disorder.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0976",
      "difficulty": "medium"
    },
    {
      "text": "A mother started to feel sad and tearful over the first two weeks following childbirth. She felt overwhelmed by the responsibilities of nursing her baby and changing diapers and waking up in the middle of the night. She felt that she was a failure as a mother. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Post-partum blues"
        },
        {
          "id": 2,
          "text": "Postpartum depression"
        },
        {
          "id": 3,
          "text": "Post-partum psychosis"
        },
        {
          "id": 4,
          "text": "Post-partum anxiety"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p class=\"p1\">The given clinical scenario is suggestive of <strong>postpartum blues. </strong></p>\n<p class=\"p1\">It is characterized by a labile mood, sadness, and subjective confusion. It is thought to be due to changes in hormone levels, the stress of childbirth, and anxiety about the responsibilities of motherhood. This usually resolves spontaneously. </p>\n<p class=\"p1\">If symptoms last longer than 2 weeks, an evaluation for <strong>postpartum depression</strong> is needed.</p>\n<p>Note:  Zuranolone is the first-ever oral drug to be approved specifically for the treatment of postpartum depression. It is a neuroactive steroid that enhances the action of GABA in the brain and regulates mood. </p>\n<p> </p><hr><h3>Related Pearl: Postpartum mood disorders</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Disorders and features</strong></span></td>\n<td><span><strong>Incidence and timeline</strong></span></td>\n<td><span><strong>Harmful thoughts</strong></span></td>\n<td><span><strong>Treatment</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum blues</strong>:</span></p>\n<p><span>Depressed affect, tearfulness and fatigue</span></p>\n</td>\n<td>\n<p><span>30-75%</span></p>\n<p><span>Starts 2-3 days after delivery. Resolves within 10 days.</span></p>\n</td>\n<td><span>No thoughts of harming the baby</span></td>\n<td><span>Support and follow up</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum depression</strong>:</span></p>\n<p><span>Depressed affect, anxiety, and poor concentration</span></p>\n</td>\n<td>\n<p><span>10-15%</span></p>\n<p><span>Starts within 4 weeks from delivery (DSM 5) or 6 weeks (ICD 11) and persists for ≥ 2 weeks. </span></p>\n</td>\n<td><span>Thoughts of harming the baby often present</span></td>\n<td><span>CBT and SSRIs </span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum psychosis</strong>:</span></p>\n<p><span>Mood-congruent delusions, hallucinations</span></p>\n</td>\n<td>\n<p><span>0.1-0.2%</span></p>\n<p><span>Onset within 4 weeks postpartum (DSM 5) or 6 weeks (ICD 11)</span></p>\n</td>\n<td><span>Thoughts of harming the baby or self</span></td>\n<td><span>Hospitalization, atypical antipsychotics and ECT for refractory cases</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Zuranolone is the first-ever oral drug to be FDA-approved specifically for the treatment of postpartum depression. It is a neuroactive steroid that enhances the action of GABA in the brain and regulates mood. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6683",
      "difficulty": "easy"
    },
    {
      "text": "A woman who had delivered a healthy baby 3 weeks ago was brought to the psychiatry OPD. She intently stares at you and says that her baby was stolen from the womb by her sister. On examination she has labile mood, and is mumbling to herself. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Baby blues"
        },
        {
          "id": 2,
          "text": "Postpartum depression"
        },
        {
          "id": 3,
          "text": "Postpartum psychosis"
        },
        {
          "id": 4,
          "text": "Schizophrenia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p1\">From the given clinical scenario the patient is showing features of <strong>postpartum psychosis </strong>(depression with psychotic features).<strong>&nbsp;</strong>It<strong>&nbsp;</strong>can often begin within a few days following delivery, although the mean time of onset is usually within <strong>2 to 4 weeks</strong> of delivery.&nbsp;</p>\n<p>Characteristically, the patient begins to complain of fatigue, episodes of tearfulness, and emotional lability. Later develops,&nbsp;<strong>suspiciousness</strong>, confusion, <strong>irrational statements</strong>, and obsessive concerns about the baby's health and welfare may be present.&nbsp;Patients eventually develop <strong>delusions</strong> that involve the idea that the baby is dead or defective. <strong>Hallucinations</strong> if present may involve voices telling the patient to harm the baby or herself.&nbsp;</p><hr><h3>Related Pearl: Postpartum mood disorders</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Disorders and features</strong></span></td>\n<td><span><strong>Incidence and timeline</strong></span></td>\n<td><span><strong>Harmful thoughts</strong></span></td>\n<td><span><strong>Treatment</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum blues</strong>:</span></p>\n<p><span>Depressed affect, tearfulness and fatigue</span></p>\n</td>\n<td>\n<p><span>30-75%</span></p>\n<p><span>Starts 2-3 days after delivery. Resolves within 10 days.</span></p>\n</td>\n<td><span>No thoughts of harming the baby</span></td>\n<td><span>Support and follow up</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum depression</strong>:</span></p>\n<p><span>Depressed affect, anxiety, and poor concentration</span></p>\n</td>\n<td>\n<p><span>10-15%</span></p>\n<p><span>Starts within 4 weeks from delivery (DSM 5) or 6 weeks (ICD 11) and persists for ≥ 2 weeks. </span></p>\n</td>\n<td><span>Thoughts of harming the baby often present</span></td>\n<td><span>CBT and SSRIs </span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum psychosis</strong>:</span></p>\n<p><span>Mood-congruent delusions, hallucinations</span></p>\n</td>\n<td>\n<p><span>0.1-0.2%</span></p>\n<p><span>Onset within 4 weeks postpartum (DSM 5) or 6 weeks (ICD 11)</span></p>\n</td>\n<td><span>Thoughts of harming the baby or self</span></td>\n<td><span>Hospitalization, atypical antipsychotics and ECT for refractory cases</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Zuranolone is the first-ever oral drug to be FDA-approved specifically for the treatment of postpartum depression. It is a neuroactive steroid that enhances the action of GABA in the brain and regulates mood. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6684",
      "difficulty": "easy"
    },
    {
      "text": "What is the treatment of choice for postpartum blues?",
      "choices": [
        {
          "id": 1,
          "text": "Fluoxetine"
        },
        {
          "id": 2,
          "text": "Cognitive behavioural therapy"
        },
        {
          "id": 3,
          "text": "Lithium carbonate"
        },
        {
          "id": 4,
          "text": "Support and education"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Postpartum blues</strong> is common in mothers in the puerperal period and requires nothing more than <strong>education and support</strong>. It is characterised by a labile mood, sadness and subjective confusion. It is thought to be due to changes in hormone levels, the stress of childbirth and anxiety about the responsibilities of motherhood.</p>\n<p>If symptoms last longer than 2 weeks, an evaluation for <strong>postpartum depression</strong> is needed.</p><hr><h3>Related Pearl: Postpartum mood disorders</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Disorders and features</strong></span></td>\n<td><span><strong>Incidence and timeline</strong></span></td>\n<td><span><strong>Harmful thoughts</strong></span></td>\n<td><span><strong>Treatment</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum blues</strong>:</span></p>\n<p><span>Depressed affect, tearfulness and fatigue</span></p>\n</td>\n<td>\n<p><span>30-75%</span></p>\n<p><span>Starts 2-3 days after delivery. Resolves within 10 days.</span></p>\n</td>\n<td><span>No thoughts of harming the baby</span></td>\n<td><span>Support and follow up</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum depression</strong>:</span></p>\n<p><span>Depressed affect, anxiety, and poor concentration</span></p>\n</td>\n<td>\n<p><span>10-15%</span></p>\n<p><span>Starts within 4 weeks from delivery (DSM 5) or 6 weeks (ICD 11) and persists for ≥ 2 weeks. </span></p>\n</td>\n<td><span>Thoughts of harming the baby often present</span></td>\n<td><span>CBT and SSRIs </span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum psychosis</strong>:</span></p>\n<p><span>Mood-congruent delusions, hallucinations</span></p>\n</td>\n<td>\n<p><span>0.1-0.2%</span></p>\n<p><span>Onset within 4 weeks postpartum (DSM 5) or 6 weeks (ICD 11)</span></p>\n</td>\n<td><span>Thoughts of harming the baby or self</span></td>\n<td><span>Hospitalization, atypical antipsychotics and ECT for refractory cases</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Zuranolone is the first-ever oral drug to be FDA-approved specifically for the treatment of postpartum depression. It is a neuroactive steroid that enhances the action of GABA in the brain and regulates mood. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8645",
      "difficulty": "easy"
    },
    {
      "text": "A primigravida who is 9 weeks pregnant, with low mood, loss of appetite, anhedonia, and insomnia for the past 2 weeks was referred to the psychiatry department.  Which of the following drugs would you prescribe her?",
      "choices": [
        {
          "id": 1,
          "text": "Imipramine"
        },
        {
          "id": 2,
          "text": "Desipramine"
        },
        {
          "id": 3,
          "text": "Selegiline"
        },
        {
          "id": 4,
          "text": "Paroxetine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario is suggestive of depression. <strong>Desipramine</strong> is the <strong>safest</strong> to use amongst the given options, for <strong>depression during pregnancy. </strong></p>\n<p>Antidepressants and pregnancy:</p>\n<p>Tricyclic Antidepressants (TCA): </p>\n<ul>\n<li>Cross the placenta.</li>\n<li><strong>Imipramine</strong> - <strong>not safe</strong>, due to high anticholinergic and hypotensive properties</li>\n<li>Desipramine, nortriptyline - recommended</li>\n<li>Neonatal withdrawal effects are frequent and mild</li>\n</ul>\n<p>Mono Amine Oxidase Inhibitors (MAO-I):</p>\n<ul>\n<li>Should be <strong>avoided</strong> in <strong>pregnancy,</strong> as they increase the risk of hypertensive crisis</li>\n<li>Associated with pulmonary hypertension in newborns</li>\n</ul>\n<p>Selective Serotonin Reuptake Inhibitors (SSRI):</p>\n<ul>\n<li>Associated with preterm delivery and spontaneous abortions</li>\n<li><strong>Paroxetine</strong> - shows <strong>cardiac abnormalities</strong> in <strong>newborns</strong></li>\n<li>Citalopram, Sertraline - safer drugs</li>\n<li>Neonate shows serotonin toxicity and withdrawal symptoms</li>\n</ul>\n<p>Note: Antipsychotic drugs like olanzapine, quetiapine, and risperidone are considered safe during pregnancy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3244",
      "difficulty": "hard"
    },
    {
      "text": "For how long would you continue SSRIs for a patient who had a single episode of depression?",
      "choices": [
        {
          "id": 1,
          "text": "4 weeks after complete remission"
        },
        {
          "id": 2,
          "text": "6 months after complete remission"
        },
        {
          "id": 3,
          "text": "6 weeks after complete remission"
        },
        {
          "id": 4,
          "text": "Until complete remission"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\"><strong>SSRIs</strong> should be continued for<strong> 6-9 months</strong> <strong>after complete remission </strong>of symptoms in a patient with a single episode of depression.</p>\n<p class=\"p1\">Treatment of depression:</p>\n<div class=\"page\" title=\"Page 275\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>In recent‐onset&nbsp;<strong>mild depression</strong>, cognitive behavioural therapy (CBT) is preferred and antidepressants are not recommended.</li>\n<li>For<strong> moderate to severe depression</strong> and&nbsp;<strong>dysthymia</strong> - Antidepressants (SSRIs) + CBT.</li>\n<li>For <strong>treatment‐resistant depression</strong>, recommended strategies include augmentation with lithium or an antipsychotic or the addition of a second antidepressant.</li>\n<li><strong>For severe</strong> and<strong> treatment-resistant depression - </strong>Electroconvulsive therapy (ECT) can also be used.</li>\n</ul>\n<p>The various classes of drugs used in depression and anxiety are listed below:&nbsp;</p>\n</div>\n</div>\n</div><table>\n<tbody>\n<tr>\n<td><strong>Class of drugs</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td><strong>Selective serotonin reuptake inhibitors (SSRI)</strong></td>\n<td>\n<ul>\n<li>Fluoxetine</li>\n<li>Fluvoxamine</li>\n<li>Paroxetine</li>\n<li>Sertraline</li>\n<li>Citalopram</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Serotonin-norepinephrine reuptake inhibitors</strong></td>\n<td>\n<ul>\n<li>Venlafaxine</li>\n<li>Desvenlafaxine</li>\n<li>Duloxetine</li>\n<li>Milnacipran</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Tricyclic antidepressants</strong></td>\n<td>\n<ul>\n<li>Amitriptyline</li>\n<li>Imipramine</li>\n<li>Nortriptyline</li>\n<li>Desipramine</li>\n<li>Amoxapine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Atypical antipsychotics</strong></td>\n<td>\n<ul>\n<li>Aripiprazole</li>\n<li>Olanzapine</li>\n<li>Quetiapine</li>\n<li>Risperidone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Monoamine oxidase inhibitors (MAO)</strong></td>\n<td>\n<ul>\n<li>Isocarboxazid</li>\n<li>Selegiline</li>\n<li>Phenelzine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Atypical antidepressants</strong></td>\n<td>\n<ul>\n<li>Bupropion</li>\n<li>Trazodone</li>\n<li>Mirtazapine</li>\n<li>Mianserin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0931",
      "difficulty": "medium"
    },
    {
      "text": "A patient was treated with TCA for a major depressive episode in the hospital for 4 weeks. What is the main concern while considering his discharge from the hospital?",
      "choices": [
        {
          "id": 1,
          "text": "Need for drug monitoring"
        },
        {
          "id": 2,
          "text": "ECG monitoring for arrhythmias"
        },
        {
          "id": 3,
          "text": "Suicidal risk"
        },
        {
          "id": 4,
          "text": "Sedation being the side effect"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Suicidal thoughts</strong> or<strong> behavior </strong>are a <strong>side effect</strong> of <strong>TCAs.</strong> Therefore, the attendants of the patient <strong>should be warned</strong> regarding this when a patient gets discharged after being treated with TCAs for a major depressive episode.</p>\n<p>Tricyclic antidepressants (TCAs) are drugs that act by<strong> inhibiting</strong> the<strong> reuptake</strong> of <strong>noradrenaline</strong> and <strong>serotonin</strong> from the synaptic clefts. </p>\n<p>The side effects of TCAs are due to blockade of other receptors:</p>\n<ul>\n<li><strong>Muscarinic M receptors</strong>- constipation, dry mouth, arrhythmia</li>\n<li><strong>Histamine H<sub>1</sub> receptors</strong>- sedation</li>\n<li><strong>5HT receptors</strong> - weight gain due to increased appetite</li>\n<li><strong>Alpha<sub>1</sub> receptors</strong> - postural hypotension.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5804",
      "difficulty": "medium"
    },
    {
      "text": "What is the treatment of choice in a patient with refractory depression and suicidal thoughts?",
      "choices": [
        {
          "id": 1,
          "text": "Selective serotonin receptor inhibitors"
        },
        {
          "id": 2,
          "text": "Tricyclic antidepressants"
        },
        {
          "id": 3,
          "text": "Electroconvulsive therapy"
        },
        {
          "id": 4,
          "text": "Monoamine oxidase inhibitors"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Electroconvulsive therapy (ECT)</strong> is the treatment of choice for depression with suicidal thoughts and refractory depression.</p>\n<p>Modified ECT uses short-acting anaesthesia and short-acting muscle relaxants.</p>\n<p>Treatment of depression:</p>\n<ul>\n<li>In recent‐onset&nbsp;<strong>mild depression</strong>, cognitive behavioural therapy (CBT) is preferred and antidepressants are not recommended.</li>\n<li>For<strong> moderate to severe depression</strong> and&nbsp;<strong>dysthymia</strong> - Antidepressants (SSRIs) + CBT.</li>\n<li>For <strong>treatment‐resistant depression</strong>, recommended strategies include augmentation with lithium or an antipsychotic or the addition of a second antidepressant</li>\n<li><strong>For severe</strong> and<strong> treatment-resistant depression - </strong>Electroconvulsive therapy (ECT) can also be used.</li>\n</ul>\n<p>Somatic and newer treatment modalities for depression include:</p>\n<ul>\n<li>Vagus nerve stimulation for resistant depression</li>\n<li>Repeated transcranial magnetic stimulation</li>\n<li>Phototherapy</li>\n<li>Deep brain stimulation.</li>\n</ul><p><strong>Note</strong>: According to the Mental Health Act 2017, unmodified ECT i.e. ECT without the use of anesthesia is no longer permitted.</p><hr><h3>Related Pearl: Key points on electroconvulsive therapy</h3><p>Produces grand mal seizure in an anesthetized patient.</p>\n<p>Mechanism of action:</p>\n<ul>\n<li><strong>Neuroplasticity</strong>:<strong>&nbsp;</strong>Ability of the brain to form and reorganize synaptic connections.</li>\n<li>Increases levels of Brain-Derived Growth Factor and Vascular Endothelial Growth Factor</li>\n</ul>\n<p><strong>Indications</strong>:</p>\n<ul>\n<li>Treatment-resistant depression</li>\n<li>Severe depression with suicidal risk (most common indication)</li>\n<li>Depression with psychotic features</li>\n<li>Depressed suicidal pregnant women</li>\n<li>Refusal to eat or drink</li>\n<li>Imminent risk for suicide</li>\n<li>Neuroleptic malignant syndrome</li>\n<li>Catatonia and catatonic schizophrenia</li>\n<li>Severe agitated depression</li>\n</ul>\n<p>Electrode placement: <strong>Bifrontotemporal</strong>, <strong>right unilateral</strong>.</p>\n<p>Anesthetic agent: <strong>Methohexital</strong> (most common)</p>\n<p>Adverse effects:</p>\n<ul>\n<li>Retrograde amnesia (most common)</li>\n<li>Partial anterograde amnesia</li>\n<li>Disorientation</li>\n<li>Temporary headache</li>\n</ul>\n<p>Memory disturbances recover within 1-6 months. <strong>Safe in pregnancy</strong>.&nbsp;ECT can reverse extrapyramidal symptoms of neuroleptics.</p>\n<p>Contraindications: <strong>No absolute contraindication</strong> (raised intracranial tension is considered as a relative contraindication).</p>\n<p>Increased risk of adverse effects in:</p>\n<ul>\n<li>Severe cardiovascular disease, recent myocardial infarction</li>\n<li>Space occupying brain lesion</li>\n<li>Recent stroke, unstable aneurysm</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6685",
      "difficulty": "easy"
    },
    {
      "text": "Which is a mood stabiliser with an anti-suicidal role?",
      "choices": [
        {
          "id": 1,
          "text": "Carbamazepine"
        },
        {
          "id": 2,
          "text": "Lamotrigine"
        },
        {
          "id": 3,
          "text": "Lithium"
        },
        {
          "id": 4,
          "text": "Valproate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Lithium</strong> is a mood stabilizer with an<strong> anti-suicidal </strong>role.</p>\n<p><strong>Maintenance treatment</strong> with <strong>lithium</strong> has been shown to significantly<strong> decrease the rate of suicide </strong>in patients diagnosed with <strong>mood disorders </strong>when compared to<strong> </strong>other mood stabilizers such as carbamazepine, lamotrigine, and valproate.</p>\n<p>Lithium is also used as an augmentation agent in treatment-resistant depression. Recurrent depression with a cyclic pattern can be controlled by either lithium or imipramine. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0830",
      "difficulty": "easy"
    },
    {
      "text": "A 36-year-old woman presented with symptoms of low mood, loss of interest, loss of appetite, and sleep disturbances for the past 3 weeks. She has a history of two similar episodes over the last 3 years. She has no history of episodes of elated mood, racing thoughts, or decreased need to sleep.  Which of the following is not a risk factor for her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Short episode duration"
        },
        {
          "id": 2,
          "text": "Recurrent dysthymia"
        },
        {
          "id": 3,
          "text": "Family history of similar episodes"
        },
        {
          "id": 4,
          "text": "Concurrent non-affective psychiatric illness"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p class=\"p1\">The given clinical scenario points towards a diagnosis of <strong>recurrent depressive disorder</strong>. <strong>Long</strong> <strong>episode duration</strong> is a risk factor for recurrent depression.</p>\n<p>Risk factors:</p>\n<ul>\n<li>Family history of depression</li>\n<li>Recurrent dysthymia</li>\n<li>Concurrent non‐affective psychiatric illness</li>\n<li>Female gender </li>\n<li>Long episode duration</li>\n<li>Degree of treatment resistance</li>\n<li>Chronic medical illness</li>\n<li>Social factors (lack of confiding relationships and psychosocial stressors)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0932",
      "difficulty": "medium"
    },
    {
      "text": "An elderly gentleman presents to you with complaints of forgetfulness. He is unable to work as his memory issues were causing him distress, and he has difficulty concentrating. He also has insomnia, depressed mood, loss of appetite, and fatigue for the past two weeks. Which of the following best describes this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Alzheimer's disease"
        },
        {
          "id": 2,
          "text": "Delirium"
        },
        {
          "id": 3,
          "text": "Dementia"
        },
        {
          "id": 4,
          "text": "Pseudo-dementia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The above scenario of an&nbsp;<strong>elderly</strong> <strong>depressed patient&nbsp;</strong>with memory loss and <strong>dementia syndrome</strong>&nbsp;is suggestive of&nbsp;<strong>pseudodementia.&nbsp;</strong>This syndrome has been termed as&nbsp;dementia syndrome of depression/depression with reversible dementia.<strong>&nbsp;</strong>The condition may improve or even completely subside after the remission of depression.&nbsp;</p>\n<p>Pseudodementia is&nbsp;a condition that appears similar to dementia but <strong>does not have neurological degeneration</strong>. Such patients commonly complain of impaired concentration and forgetfulness.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0961",
      "difficulty": "medium"
    },
    {
      "text": "What is anaclitic depression?",
      "choices": [
        {
          "id": 1,
          "text": "Depression in infants when separated from primary caregiver"
        },
        {
          "id": 2,
          "text": "Depression seen in mental retardation"
        },
        {
          "id": 3,
          "text": "Depression seen in autism spectrum disorder"
        },
        {
          "id": 4,
          "text": "Depression in schizophrenia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 118\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Anaclitic depression</strong>, also known as <strong>hospitalism,</strong> is a type of depression in <strong>infants</strong> where <strong>sudden separation</strong> from their <strong>primary caregivers</strong> leads to depression, withdrawal, nonresponsiveness, and loss of milestones in the infants. However, they recover when their mothers return or when surrogate mothering is available. </p>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0389",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged woman diagnosed with depression presented to your OPD for a follow-up. You notice a characteristic sign marked by an arrow in the image. Identify this sign.",
      "choices": [
        {
          "id": 1,
          "text": "Veraguth's sign"
        },
        {
          "id": 2,
          "text": "Omega sign"
        },
        {
          "id": 3,
          "text": "Van Gogh sign"
        },
        {
          "id": 4,
          "text": "Ottoman's sign"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p class=\"p1\">In the given image, the arrow indicates <strong>Veraguth's sign </strong>or Veraguth's fold, a<strong>&nbsp;diagonal palpebral fold</strong> running from the lateral corners of the eyes, medially upward to the medial end of the eyebrows. It is a physical sign of depression.</p>\n<p>Another physical sign of depression is the&nbsp;<strong>Omega sign. </strong>In this, there is&nbsp;vertical wrinkling between the eyebrows joined at the top by a horizontal crease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d2bdce0d5324ff5acffc26bb59afd85x1200x1118.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/865944f18b7a42679eb3b74f1e0659f5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0933",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a feature of melancholia?",
      "choices": [
        {
          "id": 1,
          "text": "Severe anhedonia"
        },
        {
          "id": 2,
          "text": "Weight loss"
        },
        {
          "id": 3,
          "text": "Sleep-onset insomnia"
        },
        {
          "id": 4,
          "text": "Profound feelings of guilt over trivial events"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Sleep-onset insomnia</strong> is a characteristic feature of <strong>anxiety disorder</strong>, not melancholia.</p>\n<p><strong>Melancholia</strong> is one of the oldest terms used in psychiatry, to describe the <strong>dark mood of depression</strong>. It is still used to refer to a state of depression characterized by:</p>\n<ul>\n<li>Severe anhedonia</li>\n<li>Early morning awakening (<strong>terminal insomnia</strong>)</li>\n<li>Weight loss</li>\n<li>Profound feelings of guilt (often over trivial events)</li>\n</ul>\n<p>Melancholia is sometimes referred to as \"<strong>endogenous depression</strong>\" or depression that arises in the absence of external life stressors or precipitants.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0966",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is not a feature of a patient with hysteroid dysphoria?",
      "choices": [
        {
          "id": 1,
          "text": "Reversed vegetative symptoms"
        },
        {
          "id": 2,
          "text": "No therapeutic response to monoamine oxidase inhibitors"
        },
        {
          "id": 3,
          "text": "They experience a craving for chocolate"
        },
        {
          "id": 4,
          "text": "Impaired anticipatory pleasure is seen"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Persons with <strong>hysteroid dysphoria</strong> respond well to treatment with monoamine oxidase inhibitors.</p>\n<p>Hysteroid dysphoria is a type of <strong>atypical depression. </strong>The following features can be seen in this condition:</p>\n<ul>\n<li>Reversed vegetative symptoms:\n<ul>\n<li>Insomnia</li>\n<li>Tendency to oversleep and to overeat</li>\n<li>Mood worsens in the evening</li>\n</ul>\n</li>\n<li><strong>Extreme sensitivity to rejection</strong> (hallmark feature)</li>\n<li>Impaired anticipatory pleasure (prediction of pleasure from a future reward), but affected persons are capable of <strong>mood reactivity</strong>&nbsp;i.e., their mood brightens in response to positive events</li>\n<li>Craving for chocolate</li>\n<li>Like patients with bipolar depression, they respond preferentially to monoamine oxidase inhibitors (MAOIs).</li>\n</ul><p>Chocolate contains phenylethylamine compounds and sugars which facilitate cellular and neuronal intake of the amino acid L-tryptophan, leading to the synthesis of endogenous antidepressants in the brain. This may explain the <strong>craving for chocolate</strong> seen in some patients with depression.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1002",
      "difficulty": "medium"
    },
    {
      "text": "A 32-year-old male presents with symptoms of low mood, fatigue, and failure to experience pleasure in any activities. He also complains of insomnia and lack of concentration. These symptoms are present during most of the months of winter and completely remit during spring. The symptoms have been recurring over the past 3 years. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Major Depressive disorder"
        },
        {
          "id": 2,
          "text": "Major Depressive Disorder with seasonal pattern"
        },
        {
          "id": 3,
          "text": "Cyclothymia"
        },
        {
          "id": 4,
          "text": "Dysthymia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Major depressive disorder</strong> with<strong> seasonal pattern</strong> is the most likely diagnosis in this scenario.&nbsp;</p>\n<p>Features of major depressive disorder with seasonal pattern:<strong>&nbsp;</strong></p>\n<ul>\n<li>Onset and remission of major depressive episodes at <strong>specific times of the year.</strong></li>\n<li>In most cases, the episodes begin in the&nbsp;fall or winter and remit in spring.</li>\n<li>This pattern of onset and remission of episodes must have occurred during at least a<strong> 2-year period</strong>, <strong>without any</strong><br /><strong>nonseasonal episodes</strong> during this period.</li>\n<li>In addition, the seasonal depressive episodes must substantially <strong>outnumber any nonseasonal depressive episodes</strong> over the individual's lifetime.</li>\n<li>Absence of seasonally linked psychosocial stressors (e.g., seasonal unemployment or school schedule).</li>\n<li>Major depressive episodes that occur in a seasonal pattern are often characterized by prominent energy, hypersomnia, overeating, weight gain, and a craving for carbohydrates.</li>\n</ul>\n<p>Note:&nbsp;According to ICD-11, seasonal depressive disorder is included under recurrent depressive disorders.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1019",
      "difficulty": "easy"
    },
    {
      "text": "A 32-year-old man presents with symptoms of low mood, fatigue, and inability to experience pleasure in any activities. He also complains of insomnia and lack of concentration. These symptoms are present during the months of winter and completely remit during spring. On further questioning, you find that he is a laborer who is always left unemployed during the winter months. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Major depressive disorder"
        },
        {
          "id": 2,
          "text": "Major depressive disorder with seasonal pattern"
        },
        {
          "id": 3,
          "text": "Dysthymia"
        },
        {
          "id": 4,
          "text": "Cyclothymia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Major depressive disorder</strong> is the most likely diagnosis in this case. </p>\n<p>DSM-V criteria for diagnosis of depression:</p>\n<div class=\"page\" title=\"Page 365\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ol>\n<li><strong>Depressed mood</strong> most of the day</li>\n<li><strong>Anhedonia</strong>- diminished interest in day-to-day activities</li>\n<li>Significant weight loss or weight gain and/or change in appetite.</li>\n<li><strong>Insomnia</strong> or hypersomnia</li>\n<li>Psychomotor agitation or retardation</li>\n<li><strong>Fatigue</strong> or loss of energy</li>\n<li>Feelings of worthlessness or excessive, inappropriate guilt</li>\n<li><strong>Diminished ability</strong> to think or <strong>concentrate</strong>, indecisiveness</li>\n<li>Recurrent thoughts of death and suicide</li>\n</ol>\n<p>At least <strong>five out of nine</strong> symptoms must be present over a two-week period and <strong>one</strong> symptom <strong>must be depressed mood </strong>or<strong> anhedonia. </strong></p>\n</div>\n</div>\n</div>\n<p><strong>Major depressive disorder with seasonal pattern </strong>(option B) is <strong>not</strong> the <strong>diagnosis</strong> as there is<strong> the presence of a </strong><strong>psychosocial stressor</strong> (e.g., seasonal unemployment or school schedule). It is explicitly mentioned in the question that the patient always remains unemployed during the winter months which acts as the objective psychological stressor in this case.</p>\n<p><strong>Major depressive disorder with seasonal pattern</strong> refers to the <strong>onset</strong> and <strong>remission</strong> of <strong>major depressive episodes</strong> at <strong>specific times of the year</strong>. In most cases, the episodes begin in the fall or winter and remit in spring. Major depressive episodes that occur in a seasonal pattern are often characterized by prominent energy, hypersomnia, overeating, weight gain, and a craving for carbohydrates. This pattern of onset and remission of episodes must have occurred during at least a 2-year period, without any nonseasonal episodes during this period. </p>\n<p><strong>Dysthymia</strong> (option C) is the presence of a <strong>persistently depressed mood</strong> that lasts <strong>most of the day</strong> and is <strong>continuous</strong>. There are also feelings of <strong>guilt</strong>, <strong>irritability</strong>, and <strong>anger</strong> associated with it. These symptoms are present for at least 2 years. Dysthymia will also <strong>never</strong> present with an episode of <strong>mania/hypomania</strong>.</p>\n<p><strong>Cyclothymia</strong> (option D) is a <strong>mild</strong> form of <strong>bipolar II disorder</strong>, characterized by symptoms of <strong>hypomania </strong>and <strong>mild depression</strong>. Hypomania mainly includes symptoms like persistently elevated or irritable mood and abnormally increased energy lasting for at least 4 consecutive days. The depression seen in cyclothymia does not qualify the criteria for a major depressive episode.</p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1014",
      "difficulty": "hard"
    },
    {
      "text": "Phototherapy is a treatment for which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Schizophrenia"
        },
        {
          "id": 2,
          "text": "Chronic major depression"
        },
        {
          "id": 3,
          "text": "Seasonal affective disorder"
        },
        {
          "id": 4,
          "text": "Cyclothymia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Phototherapy</strong> was introduced as a treatment for <strong>seasonal affective disorder</strong>.</p>\n<p>In this disorder, patients typically experience depression as the photoperiod of the day decreases with advancing winter.&nbsp;</p>\n<p>Phototherapy typically involves exposing the affected <strong>patient&nbsp;</strong>to bright light in the range of 1,500 to 10,000 lux or more, typically with a lightbox. The patient sits in front of this lightbox&nbsp;for approximately <strong>1 to 2 hours before dawn </strong>each day.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0969",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged female patient presents with a history of loss of interest in day to day activities, weight loss, insomnia, and sadness for six months. She also recalls hearing a voice once that ordered her to kill herself. What is the DSM-V diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Major depressive disorder with psychotic features"
        },
        {
          "id": 2,
          "text": "Schizophrenia"
        },
        {
          "id": 3,
          "text": "Schizoaffective disorder"
        },
        {
          "id": 4,
          "text": "Delusional disorder"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Since the patient fulfills the DSM-V criteria for major depressive disorder and has had an episode of auditory hallucination, a diagnosis of <strong>major depressive disorder with psychotic features</strong> is made.</p>\n<p><strong>Diagnostic criteria for depression:</strong></p>\n<ol>\n<li>Depressed mood&nbsp;most of the day</li>\n<li>Anhedonia- diminished interest in day to day activities</li>\n<li>Significant weight loss or weight gain. Change in appetite.</li>\n<li>Insomnia&nbsp;or hypersomnia</li>\n<li>Psychomotor agitation or retardation</li>\n<li>Fatigue or loss of energy</li>\n<li>Feelings of worthlessness or excessive, inappropriate guilt</li>\n<li>Diminished ability to think or concentrate, indecisiveness</li>\n<li>Recurrent thoughts of death, suicidal ideation</li>\n</ol>\n<p>At least <strong>five out of nine</strong> symptoms must be present over a two week period and <strong>one</strong> symptom <strong>must be depressed mood or anhedonia.</strong></p>\n<p>In major depressive disorder with psychotic features, <strong>delusions and/or hallucinations</strong> are present along with the depression symptoms.</p><hr><h3>Related Pearl: Psychotic disorders</h3><p>Differential diagnosis of DSM-5 psychotic disorders</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Psychotic disorder</strong></span></p>\n</td>\n<td><span><strong>Criteria for diagnosis</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Brief psychotic disorder</strong></span></td>\n<td>\n<p><span>Sudden onset and a full return to function</span></p>\n<p><span>Duration: &gt; 1 day and &lt; 1 month</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Schizophreniform disorder</strong></span></td>\n<td>\n<p><span>Same symptoms as schizophrenia and functional decline not required</span></p>\n<p><span>Duration: &gt; 1 month &amp; &lt; 6 months</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Schizophrenia</strong></span></td>\n<td>\n<p><span>Requires functional decline</span></p>\n<p><span>At least 6 months (includes at least 1 month of active symptoms, can include prodromal and residual periods)</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Schizoaffective disorder</strong></span></td>\n<td>\n<p><span>With concurrent mood episode.&nbsp;</span><span>Active-phase symptoms of schizophrenia with at least a 2 weeks of lifetime history of delusions or hallucinations in absence of prominent mood symptoms</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Delusional disorder</strong></span></td>\n<td>\n<p><span>One or more delusions for &gt; 1 month</span></p>\n<p><span>No other psychotic symptoms and normal functioning apart from the direct impact of delusions</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Shared psychotic disorder (folie a deux)</strong></span></td>\n<td>\n<p><span>Development of delusions in a person who is in a close relationship (ex: spouse, child) with someone who has a delusional disorder (the inducer)</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0680",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old patient comes to the casualty with a dry mouth, decreased sweating and blurring of vision, tremors. On examination, blood pressure is low, and mydriasis is present. The patient says that he has been on psychiatric medication for the past year. Which of the following drugs is responsible for the above presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Disulfiram"
        },
        {
          "id": 2,
          "text": "Imipramine"
        },
        {
          "id": 3,
          "text": "Lithium"
        },
        {
          "id": 4,
          "text": "Valproate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The manifestations given in the question are the side effects of <strong>tricyclic antidepressants (imipramine).</strong></p>\n<p>TCAs have <strong>anticholinergic side effects </strong>such as&nbsp;dry eyes, pupillary dilation, decreased&nbsp;sweating, urinary retention, and constipation.</p>\n<p>These drugs are <strong>contraindicated</strong> in patients with <strong>glaucoma</strong> and <strong>benign prostatic hyperplasia</strong>.</p>\n<p>Side effects of tricyclic antidepressants:</p>\n<table>\n<tbody>\n<tr>\n<td>Receptor blocked</td>\n<td>Side effect</td>\n</tr>\n<tr>\n<td>Muscarinic receptor blockade</td>\n<td>Anticholinergic- dry mouth, dilated pupils, tachycardia, urinary retention</td>\n</tr>\n<tr>\n<td>Alpha 1 adrenergic receptor blockade</td>\n<td>Drowsiness, postural hypotension, sexual dysfunction</td>\n</tr>\n<tr>\n<td>H1 receptor blockade</td>\n<td>Weight gain, drowsiness</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6705",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old woman developed serotonin syndrome after receiving a single dose of imipramine. She was already being treated for depression with paroxetine. Which of the following is not seen on examination?",
      "choices": [
        {
          "id": 1,
          "text": "Tremors"
        },
        {
          "id": 2,
          "text": "Rigidity"
        },
        {
          "id": 3,
          "text": "Hypothermia"
        },
        {
          "id": 4,
          "text": "Myoclonus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Hypothermia&nbsp;is not a feature of serotonin syndrome.</p>\n<p><strong>Serotonin syndrome</strong> is characterized by 3 A&rsquo;s:</p>\n<ol>\n<li>Neuromuscular hyper<strong>a</strong>ctivity (clonus, hyperreflexia, hypertonia, tremor, and seizure)</li>\n<li><strong>A</strong>utonomic stimulation (hyperthermia, diaphoresis, diarrhoea)</li>\n<li><strong>A</strong>gitation.</li>\n</ol>\n<p>It&nbsp;can occur with any drug that increases 5-HT (eg, MAOIs, SSRIs, SNRIs, TCAs, tramadol, ondansetron, triptans, linezolid, MDMA, dextromethorphan).</p>\n<p>Treatment: Discontinuation of the offending drug, supportive management, cyproheptadine (5-HT2 receptor antagonist).</p><hr><h3>Related Pearl: Psychiatric emergency: Fever with altered mental status</h3><p>In a clinical setting of <strong>fever with altered mental status</strong>, it is important to differentiate between the following.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>&nbsp;Syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Neuroleptic malignant syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Serotonin syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Anticholinergic syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Malignant hyperthermia</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>&nbsp;Cause</strong></span></div>\n</td>\n<td>\n<div><span>Dysregulation of dopaminergic pathways</span></div>\n</td>\n<td>\n<div><span>Co-prescription of MAO-I and SSRIs leading to increased serotonin and norepinephrine levels</span></div>\n</td>\n<td>\n<div>\n<div><span>Anticholinergic i</span><span>ntoxication</span></div>\n</div>\n</td>\n<td>\n<div>\n<div><span>Halogenated anesthetics and succinylcholine leading to a</span></div>\n</div>\n<div><span>hypermetabolic response causing an increased intracellular calcium level</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Fever and altered mental status</strong></span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Muscle tone</strong></span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n<td>\n<div><span><strong>Normal</strong></span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Skin and mucosa</strong></span></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n<td>\n<div><strong><span>Dry</span></strong></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Pupils</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span><strong>Dilated</strong></span></div>\n</td>\n<td>\n<div><span><strong>Dilated</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Bowel sounds</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span>Increased</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Reflexes</strong></span></div>\n</td>\n<td>\n<div><span>Bradyreflexia</span></div>\n</td>\n<td>\n<div><span>Increased</span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n<td>\n<div><span>Stop antipsychotic;</span></div>\n<div><span>give dantrolene, bromocriptine and&nbsp;</span><span>monitor CPK levels</span></div>\n</td>\n<td>\n<div><span>Change the drug;&nbsp;</span></div>\n<div><span>give cyproheptadine</span></div>\n</td>\n<td>\n<div><span>Discontinue drug;</span></div>\n<div><span>give i.v. physostigmine</span></div>\n</td>\n<td>\n<div><span>Cooling, dantrolene, insulin, and glucose</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6917",
      "difficulty": "medium"
    }
  ]
}